+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6159574
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Introduction: Mycobacterium Tuberculosis Nucleic Acid Detection Kits

Mycobacterium tuberculosis nucleic acid detection kits identify genetic material associated with tuberculosis and support faster diagnostic decision-making than approaches that rely solely on culture. Their clinical value is strongest when molecular results are interpreted alongside symptoms, imaging, epidemiological history, and drug-susceptibility testing. Adoption is shaped by laboratory capacity, specimen quality, assay performance, affordability, regulatory requirements, and access to confirmatory testing.

Transformative Shifts in Tuberculosis Molecular Diagnosis

Tuberculosis diagnosis is shifting toward integrated molecular workflows that combine pathogen detection with indicators of drug resistance where technically and operationally appropriate. Decentralized testing, simplified sample preparation, automated platforms, and connectivity are expanding the role of nucleic acid testing beyond centralized laboratories. Persistent challenges include paucibacillary disease, extrapulmonary specimens, contamination control, supply continuity, quality assurance, and the need to link test results with treatment and public-health systems.

Cumulative Impact of Artificial Intelligence on Detection Workflows

Artificial intelligence is influencing tuberculosis diagnosis mainly through image interpretation, laboratory workflow optimization, quality-control support, and prioritization of specimens or patients for testing. These tools can complement nucleic acid detection by helping identify individuals who may need molecular confirmation, but they do not replace validated assays or clinical judgment. Responsible deployment requires representative training data, transparent performance evaluation, cybersecurity, human oversight, and monitoring for differences in accuracy across populations and care settings.

Regional Insights Across Tuberculosis Diagnostic Systems

North America generally benefits from advanced laboratory infrastructure, established molecular testing pathways, and strong quality systems, while access and turnaround time can vary across remote and underserved communities. Latin America is balancing expanded molecular diagnosis with uneven laboratory capacity, procurement complexity, and persistent barriers to care. Europe combines mature diagnostic networks with continued attention to migrant health, drug-resistant tuberculosis, and equitable access across health systems. The Middle East faces diverse burdens linked to displacement, mobility, and variable laboratory resources. Africa remains a major priority for accessible, decentralized, and robust testing, particularly where specimen transport and connectivity are constrained. Asia-Pacific contains highly diverse settings, from sophisticated national laboratory networks to high-burden areas requiring affordable point-of-care or near-point-of-care molecular solutions.

Group Insights: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN countries are addressing cross-border transmission, urban density, migration, and unequal laboratory capacity through efforts to improve referral networks and decentralized testing. BRICS members encompass substantial tuberculosis burdens and varied health-system capabilities, making interoperability, local production, procurement resilience, and resistance detection important priorities. The European Union emphasizes harmonized quality, cross-border health coordination, and access for vulnerable populations. G7 systems typically focus on high-quality surveillance, innovation, and support for global tuberculosis control. GCC countries place particular emphasis on screening and continuity of care among mobile populations, while NATO members may prioritize resilient diagnostic supply chains, preparedness, and laboratory continuity during emergencies.

Country Insights: Diverse Priorities in Fifteen National Settings

Australia and Canada must maintain access across dispersed populations and coordinate testing between regional and specialized services. Brazil and Mexico face the combined need to strengthen decentralized diagnosis, improve referral completion, and address unequal access. China and India require scalable testing linked to extensive public-health networks and resistance-management programs. France, Germany, Italy, Spain, and the United Kingdom must sustain high-quality molecular pathways while addressing vulnerable and mobile populations and regional variation in service delivery. Japan and South Korea have strong technical capabilities but continue to require appropriate testing for aging populations, imported disease, and drug resistance. Russia faces the importance of laboratory quality, resistance detection, and continuity across geographically extensive services.

Actionable Priorities for Leaders in Tuberculosis Diagnostics

Industry leaders should design assays and workflows around real clinical constraints, including difficult specimens, decentralized laboratories, intermittent infrastructure, and the need for rapid resistance-related information. They should strengthen analytical and clinical validation, external quality assessment, contamination prevention, operator training, cybersecurity, and transparent reporting of limitations. Partnerships with public-health agencies can improve procurement planning, connectivity, referral pathways, and post-market surveillance. Product strategies should also consider total workflow cost, instrument maintenance, reagent stability, waste management, and equitable access rather than focusing only on analytical performance.

Research Methodology for the Executive Summary

This summary uses a structured review framework for nucleic acid detection kits used in tuberculosis diagnosis. It considers clinical workflow, assay functionality, laboratory infrastructure, regulatory and quality requirements, public-health integration, regional health-system conditions, and the potential role of artificial intelligence. Geographic observations are presented qualitatively and are not intended as estimates, forecasts, market sizing, or market-share analysis. Conclusions should be interpreted with current clinical guidelines, national policies, product instructions, and locally verified epidemiological and procurement data.

Conclusion: Building Faster, More Equitable Tuberculosis Diagnosis

Mycobacterium tuberculosis nucleic acid detection kits are important tools for shortening diagnostic pathways and supporting timely treatment decisions, particularly when integrated with resistance testing and broader clinical assessment. Their impact depends on reliable implementation: suitable specimen collection, trained personnel, quality assurance, uninterrupted supplies, confirmatory pathways, and connection to care. The strongest long-term outcomes will come from combining validated molecular technology with equitable service design, responsible digital innovation, and sustained public-health coordination.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market, by Technology
7.1. Introduction
7.2. Loop Mediated Isothermal Amplification
7.3. Real Time PCR
7.3.1. Multiplex
7.3.1.1. Dualplex
7.3.1.2. Triplex
7.3.2. Singleplex
7.4. Transcription Mediated Amplification
8. Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market, by Specimen Type
8.1. Introduction
8.2. Blood
8.3. Sputum
8.4. Tissue
9. Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market, by Application
9.1. Introduction
9.2. Clinical Diagnosis
9.2.1. Extrapulmonary
9.2.2. Pulmonary
9.3. Drug Resistance Testing
9.3.1. First Line Drugs
9.3.2. Second Line Drugs
9.4. Research Use
9.5. Treatment Monitoring
10. Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market, by Distribution Channel
10.1. Introduction
10.2. Direct Sales
10.3. Distributor Sales
10.4. Online Sales
11. Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Becton, Dickinson and Company
15.3. Bio-Rad Laboratories, Inc.
15.4. Cepheid, Inc.
15.5. F. Hoffmann-La Roche Ltd.
15.6. Hologic, Inc.
15.7. Molbio Diagnostics Pvt. Ltd.
15.8. Norgen Biotek Corp.
15.9. QIAGEN N.V.
15.10. Sansure Biotech Inc.
15.11. SD Biosensor, Inc.
15.12. Seegene, Inc.
15.13. Thermo Fisher Scientific Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market, Years Considered for the Study
FIGURE 2. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market, Research Design
FIGURE 3. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market, Research Framework
FIGURE 4. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market, Data Triangulation
FIGURE 5. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2025 vs 2032 (%)
FIGURE 9. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Segmentation & Coverage
TABLE 2. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 3. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Loop Mediated Isothermal Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Loop Mediated Isothermal Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Loop Mediated Isothermal Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Real Time PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Real Time PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Real Time PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Multiplex Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Multiplex Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Multiplex Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Dualplex Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Dualplex Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Dualplex Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Triplex Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Triplex Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Triplex Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Singleplex Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Singleplex Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Singleplex Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Transcription Mediated Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Transcription Mediated Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Transcription Mediated Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 26. Global Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Sputum Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Sputum Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Sputum Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Tissue Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Tissue Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Tissue Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 36. Global Clinical Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Clinical Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Clinical Diagnosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Extrapulmonary Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Extrapulmonary Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Extrapulmonary Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Pulmonary Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Pulmonary Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Pulmonary Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Drug Resistance Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Drug Resistance Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Drug Resistance Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global First Line Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global First Line Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global First Line Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Second Line Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Second Line Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Second Line Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Research Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Research Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Research Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Treatment Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Treatment Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Treatment Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 61. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Distributor Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Distributor Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Distributor Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Online Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Online Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Online Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 80. North America Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. North America Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 82. North America Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 83. North America Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 84. North America Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 85. North America Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 86. North America Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 87. North America Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 88. North America Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 89. Latin America Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Latin America Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 91. Latin America Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 92. Latin America Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 93. Latin America Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 94. Latin America Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. Latin America Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 96. Latin America Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 97. Latin America Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 98. Europe Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Europe Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 100. Europe Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 101. Europe Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 102. Europe Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 103. Europe Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 104. Europe Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 105. Europe Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 106. Europe Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 107. Middle East Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Middle East Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 109. Middle East Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 110. Middle East Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 111. Middle East Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 112. Middle East Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. Middle East Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 114. Middle East Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 115. Middle East Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 116. Africa Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Africa Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 118. Africa Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 119. Africa Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 120. Africa Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 121. Africa Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. Africa Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 123. Africa Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 124. Africa Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 125. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. ASEAN Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. ASEAN Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 128. ASEAN Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 129. ASEAN Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 130. ASEAN Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 131. ASEAN Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. ASEAN Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 133. ASEAN Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 134. ASEAN Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 135. GCC Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. GCC Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 137. GCC Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 138. GCC Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 139. GCC Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 140. GCC Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. GCC Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 142. GCC Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 143. GCC Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 144. European Union Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. European Union Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 146. European Union Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 147. European Union Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 148. European Union Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 149. European Union Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. European Union Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 151. European Union Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 152. European Union Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 153. BRICS Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. BRICS Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 155. BRICS Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 156. BRICS Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 157. BRICS Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 158. BRICS Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 159. BRICS Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 160. BRICS Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 161. BRICS Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 162. G7 Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. G7 Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 164. G7 Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 165. G7 Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 166. G7 Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 167. G7 Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. G7 Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 169. G7 Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 170. G7 Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 171. NATO Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 172. NATO Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 173. NATO Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 174. NATO Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 175. NATO Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 176. NATO Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. NATO Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 178. NATO Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 179. NATO Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 180. Global Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Country, 2017-2032 (USD Million)
TABLE 181. United States Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 182. United States Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 183. United States Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 184. United States Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 185. United States Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 186. United States Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. United States Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 188. United States Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 189. United States Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 190. Canada Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 191. Canada Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 192. Canada Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 193. Canada Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 194. Canada Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 195. Canada Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 196. Canada Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 197. Canada Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 198. Canada Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 199. Mexico Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 200. Mexico Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 201. Mexico Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 202. Mexico Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 203. Mexico Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 204. Mexico Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. Mexico Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 206. Mexico Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 207. Mexico Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 208. Brazil Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 209. Brazil Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 210. Brazil Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 211. Brazil Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 212. Brazil Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 213. Brazil Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. Brazil Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 215. Brazil Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 216. Brazil Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 217. United Kingdom Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 218. United Kingdom Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 219. United Kingdom Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 220. United Kingdom Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 221. United Kingdom Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 222. United Kingdom Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 223. United Kingdom Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 224. United Kingdom Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 225. United Kingdom Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 226. Germany Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 227. Germany Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 228. Germany Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 229. Germany Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 230. Germany Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 231. Germany Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 232. Germany Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 233. Germany Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 234. Germany Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 235. France Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 236. France Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 237. France Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 238. France Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 239. France Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 240. France Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. France Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 242. France Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 243. France Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 244. Russia Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 245. Russia Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 246. Russia Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 247. Russia Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 248. Russia Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 249. Russia Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 250. Russia Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 251. Russia Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 252. Russia Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 253. Italy Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 254. Italy Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 255. Italy Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 256. Italy Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 257. Italy Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 258. Italy Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. Italy Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 260. Italy Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 261. Italy Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 262. Spain Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 263. Spain Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 264. Spain Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 265. Spain Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 266. Spain Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 267. Spain Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 268. Spain Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 269. Spain Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 270. Spain Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 271. China Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, 2017-2032 (USD Million)
TABLE 272. China Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
TABLE 273. China Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Real Time PCR, 2017-2032 (USD Million)
TABLE 274. China Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Multiplex, 2017-2032 (USD Million)
TABLE 275. China Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 276. China Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 277. China Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Clinical Diagnosis, 2017-2032 (USD Million)
TABLE 278. China Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Drug Resistance Testing, 2017-2032 (USD Million)
TABLE 279. China Mycobacterium Tuberculosis Nucleic Acid Detection Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 280. India Mycobacterium

Companies Mentioned

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cepheid, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Molbio Diagnostics Pvt. Ltd.
  • Norgen Biotek Corp.
  • QIAGEN N.V.
  • Sansure Biotech Inc.
  • SD Biosensor, Inc.
  • Seegene, Inc.
  • Thermo Fisher Scientific Inc.